Navigation Links
Silencing signals sent by parasite could aid sleeping sickness fight
Date:12/15/2013

A new discovery by scientists could help combat the spread of sleeping sickness.

Insights into how the parasites that cause the disease are able to communicate with one another could help limit the spread of the infection.

The findings suggest that new drugs could be designed to disrupt the flow of messages sent between these infectious microorganisms.

Sleeping sickness so named because it disrupts sleep patterns is transmitted by the bite of the tsetse fly, and more than 69 million people in Africa are at risk of infection. Untreated, it can damage the nervous system, leading to coma, organ failure and death.

During infection, the parasites known as African trypanosomes multiply in the bloodstream and communicate with each other by releasing a small molecule. When levels of this molecule become sufficiently high, this acts as a signal for the parasites to stop replicating and to change into a form that can be picked up by biting flies and spread.

A team led by researchers at the University of Edinburgh were able to uncover key components of the parasites' messaging system. They used a technique known as gene silencing, to identify those genes that are used to respond to the communication signals and the mechanisms involved.

Professor Keith Matthews, of the University of Edinburgh's School of Biological Sciences, who led the research, said: "Parasites are adept at communicating with one another to promote their survival in our bodies and ensure their spread but by manipulating their messages, new ways to combat these infections are likely to emerge."

The research, carried out in collaboration with the University of Dundee, was published in the journal Nature, and funded by the Wellcome Trust.


'/>"/>

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert  

Page: 1

Related biology news :

1. Gene-silencing data now publicly available to help scientists better understand disease
2. Gene-silencing study finds new targets for Parkinsons disease
3. First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
4. CSHL researchers solve structure of human protein critical for silencing genes
5. Plant research reveals new role for gene silencing protein
6. A powder to enhance NMR signals
7. How living cells solved a needle in a haystack problem to produce electrical signals
8. Artifact suppression and analysis of brain activities with EEG signals
9. Neurochemical traffic signals may open new avenues for the treatment of schizophrenia
10. Researchers discover a missing link in signals contributing to neurodegeneration
11. Social bees mark dangerous flowers with chemical signals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Silencing signals sent by parasite could aid sleeping sickness fight
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
(Date:2/27/2017)... Strategic Cyber Ventures , the industry,s first cybersecurity focused ... investment in  Polarity , the first commercial human memory-augmentation ... and is led by cybersecurity veterans Tom Kellermann ... , also a longtime cybersecurity veteran and founder of ... round of funding. This new funding will be used ...
(Date:2/21/2017)... and PORTLAND, Ore. , ... and the Avamere Family of Companies (Avamere Health Services, ... announced a six-month research study that will apply the ... eldercare at senior living and health centers. By analyzing ... hopes to gain insights into physical and environmental conditions, ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... viscoelastic material that exhibits both viscous and elastic characteristics when deformed, which is ... polymer exhibits properties to gently absorb compressive forces and return to its natural ...
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... -- NetworkNewsWire Editorial Coverage  ... Cancer remains one of the ... care systems, in terms of costs and resources. However, as ... development of innovative and efficient therapies that demonstrate higher chances ... of cancer treatments, a growing number of patients receiving immuno-oncology ...
Breaking Biology Technology: